Anti-seizure drug fights aggressive childhood brain tumors, study shows

An existing anti-seizure drug slows the growth of a devastating group of childhood cancers, new Stanford Medicine-led research has shown. The tumors, called diffuse midline gliomas, strike the brain and spinal cord. They affect 300 to 400 U.S. children per year and have a five-year survival rate of about 1%.

Read it at Medical Xpress ↗

← Front page